NCT02448173 2026-02-02
A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer
Vaccinogen Inc
Phase 3 Not yet recruiting
Vaccinogen Inc
Norwegian Department of Health and Social Affairs
Centre Hospitalier Universitaire Dijon